[Validation of the French language version of the Parkinson's Disease Questionnaire - PDQ-39]

After Alzheimer's disease, Parkinson's disease (PD) is the second most frequent degenerative disease of the central nervous system. The consequences of PD at the functional, social and emotional levels warrant a better understanding the patient's perceptions as measured using a specif...

Full description

Bibliographic Details
Main Authors: Auquier, P, Sapin, C, Ziegler, M, Tison, F, Destée, A, Dubois, B, Allicar, M, Thibault, J, Jenkinson, C, Peto, V
Format: Journal article
Language:French
Published: 2002
_version_ 1826277857478836224
author Auquier, P
Sapin, C
Ziegler, M
Tison, F
Destée, A
Dubois, B
Allicar, M
Thibault, J
Jenkinson, C
Peto, V
author_facet Auquier, P
Sapin, C
Ziegler, M
Tison, F
Destée, A
Dubois, B
Allicar, M
Thibault, J
Jenkinson, C
Peto, V
author_sort Auquier, P
collection OXFORD
description After Alzheimer's disease, Parkinson's disease (PD) is the second most frequent degenerative disease of the central nervous system. The consequences of PD at the functional, social and emotional levels warrant a better understanding the patient's perceptions as measured using a specific instrument rather than restricting the medical approach to the clinical evaluation of the motor component. In 1996, we began implementation of a project to transculturally validate the single specific instrument that had been published and was available at that time: PDQ-39. The scale consists in a 39-item questionnaire enabling determination of an overall quality-of-life score and scores for 8 specific dimensions: mobility, activities of daily living, emotional well-being, stigma, social support, cognitions, communication and bodily discomfort. Eighty-nine patients taking part in an open-label study of the safety of a combination of pergolide and dopa therapy were included and followed up on D15 and after 8 weeks. The process of "Forward-Backward" translation, conducted in close liaison with the authors, enabled semantic and linguistic validation of the French language version. The content was validated by PD experts. At baseline, the patients presented quality-of-life scores that were particularly impaired for the dimensions exploring Mobility, Emotional well-being and Bodily discomfort. The main metric properties of the scale were confirmed. The PDQ-39 scores were closely correlated with the related concepts investigated by generic scale, SF-36. The PDQ-39 scores were correlated with the "Mental and Mood Status", "Everyday Activities" and "Motor Status" dimensions determined by the UPDRS. The reliability, expressed by Cronbach coefficients alpha, showed strong consistency of the instrument, very similar to the data for the original version. In contrast to what was observed with SF-36, the scale was particularly sensitive to clinical changes. The initial results make PDQ-39 a precious tool for the optimization of management of patients presenting with PD.
first_indexed 2024-03-06T23:35:13Z
format Journal article
id oxford-uuid:6d6dc4bf-6885-4366-8a77-78217d5191fa
institution University of Oxford
language French
last_indexed 2024-03-06T23:35:13Z
publishDate 2002
record_format dspace
spelling oxford-uuid:6d6dc4bf-6885-4366-8a77-78217d5191fa2022-03-26T19:17:43Z[Validation of the French language version of the Parkinson's Disease Questionnaire - PDQ-39]Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:6d6dc4bf-6885-4366-8a77-78217d5191faFrenchSymplectic Elements at Oxford2002Auquier, PSapin, CZiegler, MTison, FDestée, ADubois, BAllicar, MThibault, JJenkinson, CPeto, VAfter Alzheimer's disease, Parkinson's disease (PD) is the second most frequent degenerative disease of the central nervous system. The consequences of PD at the functional, social and emotional levels warrant a better understanding the patient's perceptions as measured using a specific instrument rather than restricting the medical approach to the clinical evaluation of the motor component. In 1996, we began implementation of a project to transculturally validate the single specific instrument that had been published and was available at that time: PDQ-39. The scale consists in a 39-item questionnaire enabling determination of an overall quality-of-life score and scores for 8 specific dimensions: mobility, activities of daily living, emotional well-being, stigma, social support, cognitions, communication and bodily discomfort. Eighty-nine patients taking part in an open-label study of the safety of a combination of pergolide and dopa therapy were included and followed up on D15 and after 8 weeks. The process of "Forward-Backward" translation, conducted in close liaison with the authors, enabled semantic and linguistic validation of the French language version. The content was validated by PD experts. At baseline, the patients presented quality-of-life scores that were particularly impaired for the dimensions exploring Mobility, Emotional well-being and Bodily discomfort. The main metric properties of the scale were confirmed. The PDQ-39 scores were closely correlated with the related concepts investigated by generic scale, SF-36. The PDQ-39 scores were correlated with the "Mental and Mood Status", "Everyday Activities" and "Motor Status" dimensions determined by the UPDRS. The reliability, expressed by Cronbach coefficients alpha, showed strong consistency of the instrument, very similar to the data for the original version. In contrast to what was observed with SF-36, the scale was particularly sensitive to clinical changes. The initial results make PDQ-39 a precious tool for the optimization of management of patients presenting with PD.
spellingShingle Auquier, P
Sapin, C
Ziegler, M
Tison, F
Destée, A
Dubois, B
Allicar, M
Thibault, J
Jenkinson, C
Peto, V
[Validation of the French language version of the Parkinson's Disease Questionnaire - PDQ-39]
title [Validation of the French language version of the Parkinson's Disease Questionnaire - PDQ-39]
title_full [Validation of the French language version of the Parkinson's Disease Questionnaire - PDQ-39]
title_fullStr [Validation of the French language version of the Parkinson's Disease Questionnaire - PDQ-39]
title_full_unstemmed [Validation of the French language version of the Parkinson's Disease Questionnaire - PDQ-39]
title_short [Validation of the French language version of the Parkinson's Disease Questionnaire - PDQ-39]
title_sort validation of the french language version of the parkinson s disease questionnaire pdq 39
work_keys_str_mv AT auquierp validationofthefrenchlanguageversionoftheparkinsonsdiseasequestionnairepdq39
AT sapinc validationofthefrenchlanguageversionoftheparkinsonsdiseasequestionnairepdq39
AT zieglerm validationofthefrenchlanguageversionoftheparkinsonsdiseasequestionnairepdq39
AT tisonf validationofthefrenchlanguageversionoftheparkinsonsdiseasequestionnairepdq39
AT desteea validationofthefrenchlanguageversionoftheparkinsonsdiseasequestionnairepdq39
AT duboisb validationofthefrenchlanguageversionoftheparkinsonsdiseasequestionnairepdq39
AT allicarm validationofthefrenchlanguageversionoftheparkinsonsdiseasequestionnairepdq39
AT thibaultj validationofthefrenchlanguageversionoftheparkinsonsdiseasequestionnairepdq39
AT jenkinsonc validationofthefrenchlanguageversionoftheparkinsonsdiseasequestionnairepdq39
AT petov validationofthefrenchlanguageversionoftheparkinsonsdiseasequestionnairepdq39